Yousif Capital Management LLC Sells 444 Shares of Maximus, Inc. $MMS

Yousif Capital Management LLC cut its stake in shares of Maximus, Inc. (NYSE:MMSFree Report) by 2.2% during the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 20,059 shares of the health services provider’s stock after selling 444 shares during the period. Yousif Capital Management LLC’s holdings in Maximus were worth $1,408,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also recently modified their holdings of the company. Caitong International Asset Management Co. Ltd increased its position in shares of Maximus by 17,533.3% in the first quarter. Caitong International Asset Management Co. Ltd now owns 529 shares of the health services provider’s stock worth $36,000 after purchasing an additional 526 shares during the last quarter. GAMMA Investing LLC increased its position in shares of Maximus by 67.1% in the first quarter. GAMMA Investing LLC now owns 732 shares of the health services provider’s stock worth $50,000 after purchasing an additional 294 shares during the last quarter. UMB Bank n.a. increased its position in shares of Maximus by 37.5% in the second quarter. UMB Bank n.a. now owns 833 shares of the health services provider’s stock worth $58,000 after purchasing an additional 227 shares during the last quarter. Blue Trust Inc. increased its position in shares of Maximus by 32.8% in the first quarter. Blue Trust Inc. now owns 1,228 shares of the health services provider’s stock worth $84,000 after purchasing an additional 303 shares during the last quarter. Finally, IFP Advisors Inc increased its position in shares of Maximus by 70.8% in the second quarter. IFP Advisors Inc now owns 1,558 shares of the health services provider’s stock worth $109,000 after purchasing an additional 646 shares during the last quarter. 97.21% of the stock is currently owned by institutional investors.

Wall Street Analysts Forecast Growth

Several research firms recently weighed in on MMS. Weiss Ratings upgraded shares of Maximus from a “hold (c+)” rating to a “buy (b-)” rating in a research report on Wednesday, October 8th. Zacks Research upgraded shares of Maximus from a “hold” rating to a “strong-buy” rating in a research report on Tuesday, August 26th. One equities research analyst has rated the stock with a Strong Buy rating and two have issued a Buy rating to the company. According to MarketBeat, the company has an average rating of “Buy” and an average target price of $90.00.

View Our Latest Analysis on Maximus

Insider Activity

In other Maximus news, insider Michelle F. Link sold 1,610 shares of the business’s stock in a transaction dated Wednesday, October 1st. The stock was sold at an average price of $90.86, for a total transaction of $146,284.60. Following the completion of the sale, the insider directly owned 13,508 shares in the company, valued at $1,227,336.88. The trade was a 10.65% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. 1.60% of the stock is currently owned by corporate insiders.

Maximus Price Performance

NYSE MMS opened at $87.15 on Tuesday. Maximus, Inc. has a one year low of $63.77 and a one year high of $93.73. The stock has a 50-day moving average of $87.56 and a 200 day moving average of $76.88. The company has a market capitalization of $4.91 billion, a price-to-earnings ratio of 16.05 and a beta of 0.57. The company has a debt-to-equity ratio of 0.91, a quick ratio of 2.27 and a current ratio of 2.27.

Maximus (NYSE:MMSGet Free Report) last released its quarterly earnings data on Thursday, August 7th. The health services provider reported $2.16 EPS for the quarter, topping the consensus estimate of $1.39 by $0.77. Maximus had a return on equity of 24.44% and a net margin of 5.83%.The company had revenue of $1.35 billion during the quarter, compared to the consensus estimate of $1.29 billion. During the same period last year, the company earned $1.74 EPS. Maximus’s revenue for the quarter was up 2.5% on a year-over-year basis. Maximus has set its FY 2025 guidance at 7.350-7.550 EPS. On average, sell-side analysts forecast that Maximus, Inc. will post 6.15 EPS for the current year.

Maximus Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Monday, December 1st. Shareholders of record on Friday, November 14th will be paid a dividend of $0.30 per share. This represents a $1.20 dividend on an annualized basis and a dividend yield of 1.4%. The ex-dividend date is Friday, November 14th. Maximus’s payout ratio is currently 22.10%.

About Maximus

(Free Report)

Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.

Read More

Institutional Ownership by Quarter for Maximus (NYSE:MMS)

Receive News & Ratings for Maximus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Maximus and related companies with MarketBeat.com's FREE daily email newsletter.